Sept-ah naupangte vaccine pek theih beisei

ICMR chuan naupang, kum 2-18 inkar tana Covaxin chu phase II leh III trial neih mek a ni tih sawiin, result pawh hriat theih thuai beisei a nih thu a sawi. September thlaah chuan naupangte hnenah vaccine hi pekchhuah theih an rin thu an sawi. Covaxin bakah naupangte hman tur hian Zydus Cadila vaccine pawh enchhin mek a ni bawk. Zydus Cadila hi hman tura pawm a nih chuan DNA vaccine hman hmasa ber a ni ang.

Bharat Biotech siam, Covaxin hi kum 12-18 inkar, volunteer 525-ah enchhin niin, Zydus Cadila siam ZyCov-D hi volunteer 1,000-ah enchhin an ni.